Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 126 clinical trials
Featured trial
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209) (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblatoma (GBM) or other primary CNS tumors with an activating FGFR1-3 mutation or fusion/rearrangement. This study consists of 3 cohorts, Cohorts A, B, and C, and will enroll approximately 82, 82, and 25 participants into each cohort, respectively. …

karnofsky performance status
recurrent tumor
oligodendroglioma
EGFR
FGFR1
  • 3 views
  • 22 Oct, 2022
  • 27 locations
Featured trial
Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program

Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program

  • 58 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program

Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program

  • 72 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Biofilm Epidemiology and Mechanisms in Colon Cancer

Biofilm Epidemiology and Mechanisms in Colon Cancer

  • 130 views
  • 23 Nov, 2020
  • 1 location
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Patients With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with endocrine therapy of physician's choice in participants with medium- and high-risk Stage I-III histologically confirmed estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.

  • 21 views
  • 15 Oct, 2022
  • 654 locations
Phase II Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

eRapa (encapsulated rapamycin) will be investigated for secondary prevention in patients with diagnosed non-muscle invasive bladder cancer (NMIBC) through a phase II double-blind randomized controlled trial of long-term (one year) prevention with eRapa versus placebo. The primary hypothesis is that eRapa decreases the risk of cancer relapse for patients with …

  • 0 views
  • 11 Oct, 2022
  • 3 locations
RANKL Inhibition and Mammographic Breast Density (TRIDENT)

adoption of RANKL inhibition in primary breast cancer prevention are not yet available. The hypothesis is that RANKL inhibition with denosumab will decrease mammographic density in high-risk premenopausal

  • 0 views
  • 23 Apr, 2022
  • 1 location
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation

Radiotherapy (RT) is a well-known and established therapy or adjuvant therapy for the treatment of thoracic cancer It uses a high energy radiation from x-rays, gamma rays and other charged particles that assist in damaging the cancer DNA. PET/MR as imaging biomarkers for cardiopulmonary dysfunction with a focus on Pulmonary …

cancer
  • 0 views
  • 08 Oct, 2021
  • 1 location
Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon (PCCCP)

In sub-Saharan Africa, cervical cancer is the leading cause of cancer death among women because of the difficulty in implementing screening programs. The main obstacles in these countries are poverty, lack of healthcare infrastructures and trained practitioners. With the availability of new technologies, researchers are looking for new strategies adapted …

papilloma
cancer prevention
smear
Accepts healthy volunteers
colposcopy
  • 6 views
  • 01 Feb, 2022
  • 1 location
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

This study aimed to investigate the effect of low-dose (100 mg) asprin on the prevention of gastric cancer in the early gastric cancer patients with negative H. pylori status who underwent endoscopic submucosal dissection.

early gastric cancer
endoscopic submucosal dissection
  • 0 views
  • 23 May, 2021
  • 13 locations